Fig. 2
From: Comparison of pharmaceutical pricing and reimbursement systems in Turkey and certain EU countries
Source: IMS Market Prognosis Sept. 2015; at ex-manufacturer price level, without rebates and discounts
Expected growth rate
Fig. 2 | SpringerPlus